share_log

Cigna Group's (NYSE:CI) Earnings Growth Rate Lags the 20% CAGR Delivered to Shareholders

Cigna Group's (NYSE:CI) Earnings Growth Rate Lags the 20% CAGR Delivered to Shareholders

Cigna集團(紐交所:CI)的盈利增速低於向股東提供的20%複合年增長率。
Simply Wall St ·  09/27 07:15

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put in. But on the bright side, you can make far more than 100% on a really good stock. Long term The Cigna Group (NYSE:CI) shareholders would be well aware of this, since the stock is up 132% in five years. But it's down 3.4% in the last week.

購買公司股票後的最糟糕結果(假設沒有槓桿)是失去投入的所有資金。但值得一提的是,您在一支表現非常好的股票上的回報可能遠遠超過100%。 長揸紐交所(NYSE:CI)的股東一定對此心知肚明,因爲該股在五年內上漲了132%。但在過去一週下跌了3.4%。

While the stock has fallen 3.4% this week, it's worth focusing on the longer term and seeing if the stocks historical returns have been driven by the underlying fundamentals.

雖然本週股價下跌了3.4%,但值得關注的是更長的期限,並查看股票的歷史回報是否由基本面驅動。

There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price.

市場有時毫無疑問是有效的,但股票價格並不總是反映基本業務表現。一種有缺陷但合理的方法是比較每股收益(EPS)和股票價格,以評估圍繞公司的情緒如何變化。

During five years of share price growth, Cigna Group achieved compound earnings per share (EPS) growth of 2.5% per year. This EPS growth is lower than the 18% average annual increase in the share price. This suggests that market participants hold the company in higher regard, these days. That's not necessarily surprising considering the five-year track record of earnings growth.

在五年的股價增長期間,信諾(The Cigna Group)實現了每股收益(EPS)複合增長率爲2.5%每年。這種EPS增長率低於股價年均增長率18%的平均水平。這表明市場參與者目前更看好這家公司。考慮到過去五年的盈利增長記錄,這並不奇怪。

The company's earnings per share (over time) is depicted in the image below (click to see the exact numbers).

該公司的每股收益(隨時間的推移)如下圖所示(單擊可查看確切數字)。

big
NYSE:CI Earnings Per Share Growth September 27th 2024
紐交所:信諾2024年9月27日每股收益增長

Before buying or selling a stock, we always recommend a close examination of historic growth trends, available here.

在購買或出售股票之前,我們始終建議對歷史增長趨勢進行仔細研究,可以在這裏找到相關信息。

What About Dividends?

那麼分紅怎麼樣呢?

It is important to consider the total shareholder return, as well as the share price return, for any given stock. The TSR is a return calculation that accounts for the value of cash dividends (assuming that any dividend received was reinvested) and the calculated value of any discounted capital raisings and spin-offs. Arguably, the TSR gives a more comprehensive picture of the return generated by a stock. We note that for Cigna Group the TSR over the last 5 years was 148%, which is better than the share price return mentioned above. And there's no prize for guessing that the dividend payments largely explain the divergence!

對於任何給定的股票,考慮總股東回報以及股價回報是非常重要的。 TSR是一種回報計算,它考慮了現金股利的價值(假設任何股利都已被再投資)以及任何折現的增資和分拆的計算價值。可以說,TSR提供了關於股票產生的回報的更全面的圖片。我們注意到,信諾集團過去5年的TSR爲148%,比上面提到的股價回報要好。毫無疑問,股息支付在很大程度上解釋了這種背離!

A Different Perspective

不同的觀點

Cigna Group provided a TSR of 21% over the last twelve months. Unfortunately this falls short of the market return. The silver lining is that the gain was actually better than the average annual return of 20% per year over five year. It is possible that returns will improve along with the business fundamentals. It's always interesting to track share price performance over the longer term. But to understand Cigna Group better, we need to consider many other factors. Consider risks, for instance. Every company has them, and we've spotted 3 warning signs for Cigna Group you should know about.

信諾集團在過去一年提供了21%的TSR。不幸的是,這低於市場回報。幸運的是,這一收益實際上比過去五年每年20%的平均回報更好。隨着業務基本面的改善,回報有可能會提高。跟蹤長期的股價表現總是很有趣。但要更好地了解信諾集團,我們需要考慮許多其他因素。例如,考慮風險。每家公司都面臨着風險,我們已經發現了3個有關信諾集團的警示信號,您應該知道。

We will like Cigna Group better if we see some big insider buys. While we wait, check out this free list of undervalued stocks (mostly small caps) with considerable, recent, insider buying.

如果我們看到一些內部人員大量買入,我們會更喜歡信諾集團。在等待的時候,可以查看這份免費的低估股票名單(主要是小盤股),其中包含相當多近期的內部買入。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

請注意,本文所引述的市場回報反映了目前在美國交易所上市的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論